<SEC-DOCUMENT>0000950170-25-033665.txt : 20250305
<SEC-HEADER>0000950170-25-033665.hdr.sgml : 20250305
<ACCEPTANCE-DATETIME>20250305162805
ACCESSION NUMBER:		0000950170-25-033665
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250303
FILED AS OF DATE:		20250305
DATE AS OF CHANGE:		20250305

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hunt Jonathan Robert
		CENTRAL INDEX KEY:			0001375410
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33407
		FILM NUMBER:		25711571

	MAIL ADDRESS:	
		STREET 1:		2401 ELLIOTT AVENUE
		STREET 2:		SUITE 320
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Perspective Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000728387
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				411458152
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2401 ELLIOTT AVENUE
		STREET 2:		SUITE 320
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		206-676-0900

	MAIL ADDRESS:	
		STREET 1:		2401 ELLIOTT AVENUE
		STREET 2:		SUITE 320
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Isoray, Inc.
		DATE OF NAME CHANGE:	20181231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IsoRay, Inc.
		DATE OF NAME CHANGE:	20050805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CENTURY PARK PICTURES CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-03-03</periodOfReport>

    <issuer>
        <issuerCik>0000728387</issuerCik>
        <issuerName>Perspective Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>CATX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001375410</rptOwnerCik>
            <rptOwnerName>Hunt Jonathan Robert</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PERSPECTIVE THERAPEUTICS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>2401 ELLIOTT AVENUE, SUITE 320</rptOwnerStreet2>
            <rptOwnerCity>SEATTLE</rptOwnerCity>
            <rptOwnerState>WA</rptOwnerState>
            <rptOwnerZipCode>98121</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>false</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>Chief Accounting Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.46</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2025-03-03</value>
                <footnoteId id="F1"/>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>75000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2035-03-03</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>75000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>75000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 13, 2025, with a grant date of March 3, 2025 (the &quot;Grant Date&quot;), and represents the Reporting Person's annual equity award for 2025.</footnote>
        <footnote id="F2">Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact</signatureName>
        <signatureDate>2025-03-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
